VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 113 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,106,758 | -32.6% | 2,465,388 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $28,366,231 | +346.6% | 2,477,400 | +200.7% | 0.00% | – |
| Q1 2023 | $6,351,397 | +23.5% | 823,787 | -2.3% | 0.00% | – |
| Q4 2022 | $5,141,837 | +47.1% | 842,924 | +42.7% | 0.00% | – |
| Q3 2022 | $3,496,000 | +4.9% | 590,504 | +4.7% | 0.00% | – |
| Q2 2022 | $3,334,000 | -14.9% | 564,215 | +9.7% | 0.00% | – |
| Q1 2022 | $3,919,000 | +211.0% | 514,155 | +10.6% | 0.00% | – |
| Q4 2021 | $1,260,000 | -48.5% | 464,836 | -50.1% | 0.00% | – |
| Q3 2021 | $2,447,000 | -37.1% | 930,735 | -1.3% | 0.00% | – |
| Q2 2021 | $3,893,000 | -67.2% | 942,666 | -62.6% | 0.00% | – |
| Q1 2021 | $11,882,000 | -34.3% | 2,522,420 | -0.3% | 0.00% | -100.0% |
| Q4 2020 | $18,088,000 | -34.2% | 2,529,731 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $27,476,000 | -17.2% | 2,575,103 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $33,175,000 | +50.6% | 2,628,767 | +9.2% | 0.00% | 0.0% |
| Q1 2020 | $22,029,000 | -25.4% | 2,407,352 | +13.7% | 0.00% | 0.0% |
| Q4 2019 | $29,535,000 | -19.3% | 2,117,194 | -0.5% | 0.00% | -50.0% |
| Q3 2019 | $36,607,000 | -35.3% | 2,127,104 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $56,605,000 | +56.1% | 2,079,554 | +9.8% | 0.00% | 0.0% |
| Q1 2019 | $36,251,000 | +107.4% | 1,893,972 | +1.9% | 0.00% | +100.0% |
| Q4 2018 | $17,477,000 | -50.4% | 1,859,018 | -0.3% | 0.00% | -50.0% |
| Q3 2018 | $35,262,000 | -2.2% | 1,863,766 | +1.0% | 0.00% | 0.0% |
| Q2 2018 | $36,066,000 | +33.5% | 1,845,706 | +28.3% | 0.00% | +100.0% |
| Q1 2018 | $27,020,000 | +34.4% | 1,438,029 | +18.8% | 0.00% | 0.0% |
| Q4 2017 | $20,099,000 | +40.2% | 1,210,763 | +73.9% | 0.00% | 0.0% |
| Q3 2017 | $14,339,000 | +139.4% | 696,418 | +4.2% | 0.00% | – |
| Q2 2017 | $5,990,000 | -15.6% | 668,433 | +24.8% | 0.00% | – |
| Q1 2017 | $7,094,000 | +13542.3% | 535,727 | +12966.5% | 0.00% | – |
| Q4 2016 | $52,000 | -26.8% | 4,100 | -30.8% | 0.00% | – |
| Q3 2016 | $71,000 | +9.2% | 5,927 | 0.0% | 0.00% | – |
| Q2 2016 | $65,000 | +6400.0% | 5,927 | +6635.2% | 0.00% | – |
| Q1 2016 | $1,000 | – | 88 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |